TENON MEDICAL INC (TNON) Stock Price, Quote, News and Overview
NASDAQ:TNON - Nasdaq - US88066N3035 - Common Stock - Currency: USD
TNON Quote, Performance and Key Statistics
NASDAQ:TNON (6/20/2025, 10:10:09 AM)
0.91
+0.03 (+3.41%)
The current stock price of TNON is 0.91 USD. In the past month the price decreased by -24.71%. In the past year, price decreased by -80.68%.
TNON Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 27.68 | 230.20B | ||
| ISRG | INTUITIVE SURGICAL INC | 67.1 | 183.75B | ||
| BSX | BOSTON SCIENTIFIC CORP | 37.62 | 150.27B | ||
| SYK | STRYKER CORP | 29.98 | 143.55B | ||
| MDT | MEDTRONIC PLC | 15.67 | 110.50B | ||
| BDX | BECTON DICKINSON AND CO | 11.99 | 48.43B | ||
| EW | EDWARDS LIFESCIENCES CORP | 28.62 | 43.64B | ||
| IDXX | IDEXX LABORATORIES INC | 45.74 | 42.25B | ||
| RMD | RESMED INC | 27.74 | 36.94B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 15.7 | 33.06B | ||
| DXCM | DEXCOM INC | 49.12 | 31.78B | ||
| STE | STERIS PLC | 25.32 | 23.23B |
Related stock screener links
About TNON
Company Profile
Tenon Medical, Inc. is a medical device company, which engages in the development of a minimally invasive approach to the sacroiliac joint (SI joint) using a single titanium implant for treatment of the most common types of SI Joint disorders. The company is headquartered in Los Gatos, California and currently employs 27 full-time employees. The company went IPO on 2022-04-27. The firm has developed the Catamaran SI Joint Fusion System that offers a novel, less invasive approach to the SI joint using a single, robust titanium implant. The system features the Catamaran Fixation Device which passes through both the axial and sagittal planes of the ilium and sacrum, stabilizing and transfixing the SI Joint along its longitudinal axis. The angle and trajectory of the Catamaran surgical approach is also designed to provide a pathway away from critical neural and vascular structures and into the strongest cortical bone. The Catamaran System is designed specially to resist vertical shear and rotation of the joint in which it was implanted, helping stabilize the joint in preparation for eventual fusion. The firm has also developed a proprietary two-dimensional (2D) placement protocol as well as a protocol for three-dimensional (3D) navigation utilizing the latest techniques in spine surgery.
Company Info
TENON MEDICAL INC
104 Cooper Ct.
Los Gatos CALIFORNIA US
Employees: 21
Phone: 14086495760
TENON MEDICAL INC / TNON FAQ
What is the stock price of TENON MEDICAL INC today?
The current stock price of TNON is 0.91 USD. The price increased by 3.41% in the last trading session.
What is the ticker symbol for TENON MEDICAL INC stock?
The exchange symbol of TENON MEDICAL INC is TNON and it is listed on the Nasdaq exchange.
On which exchange is TNON stock listed?
TNON stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for TENON MEDICAL INC stock?
8 analysts have analysed TNON and the average price target is 5.95 USD. This implies a price increase of 553.84% is expected in the next year compared to the current price of 0.91. Check the TENON MEDICAL INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is TENON MEDICAL INC worth?
TENON MEDICAL INC (TNON) has a market capitalization of 6.91M USD. This makes TNON a Nano Cap stock.
How many employees does TENON MEDICAL INC have?
TENON MEDICAL INC (TNON) currently has 21 employees.
Is TENON MEDICAL INC (TNON) expected to grow?
The Revenue of TENON MEDICAL INC (TNON) is expected to grow by 26.87% in the next year. Check the estimates tab for more information on the TNON EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy TENON MEDICAL INC (TNON) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of TNON, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of TNON, evaluating the profitability, health, valuation and growth aspects
- TENON MEDICAL INC (TNON) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- TENON MEDICAL INC (TNON) Sales and EPS estimates to see what analysts future expectations are.
- TENON MEDICAL INC (TNON) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- TENON MEDICAL INC (TNON) Insider and Institutional Ownership to learn about the owners and their transactions.
- TENON MEDICAL INC (TNON) Stock Chart to make your own analysis
- TENON MEDICAL INC (TNON) Latest news and press-releases to stay up to date.
Does TENON MEDICAL INC (TNON) stock pay dividends?
TNON does not pay a dividend.
When does TENON MEDICAL INC (TNON) report earnings?
TENON MEDICAL INC (TNON) will report earnings on 2025-08-11, after the market close.
What is the Price/Earnings (PE) ratio of TENON MEDICAL INC (TNON)?
TENON MEDICAL INC (TNON) does not have a PE ratio as the earnings reported over the last twelve months were negative (-15.34).
What is the Short Interest ratio of TENON MEDICAL INC (TNON) stock?
The outstanding short interest for TENON MEDICAL INC (TNON) is 0.23% of its float. Check the ownership tab for more information on the TNON short interest.
TNON Technical Analysis
TNON Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to TNON. While TNON has a great health rating, there are worries on its profitability.
TNON Financial Highlights
Over the last trailing twelve months TNON reported a non-GAAP Earnings per Share(EPS) of -15.34. The EPS increased by 71.34% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -102.38% | ||
| ROE | -146.26% | ||
| Debt/Equity | 0 |
TNON Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 83% to TNON. The Buy consensus is the average rating of analysts ratings from 8 analysts.
For the next year, analysts expect an EPS growth of 88.72% and a revenue growth 26.87% for TNON